Lenvatinib as Second-Line Treatment in Patients With Unresectable Hepatocellular Carcinoma: A Retrospective Analysis
Recommended
Lenvatinib as Second-Line Treatment in Patients With Unresectable Hepatocellular Carcinoma: A Retrospective Analysis
The purpose of this study is to determine the efficacy and safety of lenvatinib as second-line therapy in Chinese patients with unresectable hepatocellular carcinoma (HCC).
<!-- BEGIN ADVERTSERVE CODE -->
<div id="mobile_block_ad_1"><script type="text/javascript">
var _avp = _avp || [];
_avp.push({ tagid: 'mobile_block_ad_1', alias: '/', type: 'banner', zid: 1669, pid: 0, onscroll: 0, inview: true, secure: true });
</script></div>
<!-- END ADVERTSERVE CODE -->